Navigation Links
Valencell Secures $11 Million in Series D Funding

RALEIGH, N.C., March 8, 2016 /PRNewswire/ -- Valencell, the leading innovator in performance biometric sensor technology, today announced it has secured $11M in Series D financing. The investment is led by GII Tech, a new venture fund being launched by UAE-based financial services company GII LLC, with additional participation from existing investors TDF Ventures and WSJ Joshua Fund. Valencell plans to use the funds to continue its triple-digit growth and accelerate its pioneering innovation in accurate biometric wearable technology. This brings the total amount of funding raised to date to $24.5 million.

"Biometric sensors are becoming 'must-have' features in wearable and hearable devices of all kinds, and the market demand for these devices is skyrocketing," said Pankaj Gupta, CEO, GII. "Valencell has solved many of the most difficult technical challenges in biometric sensors and their continued innovation has established a proven track record of bringing the next generation of biometric innovations to market. This round of funding will help the Valencell team accelerate R&D and growth initiatives to take advantage of this rapidly expanding market."

Valencell continues to see global demand for highly accurate biometric sensor technology with significant growth in both hearables and wrist wearables. In 2015, Valencell saw its second consecutive year of triple-digit growth in its PerformTek® biometric sensor technology, with a 133 percent increase in licensees over 2014. Valencell now has over 25 licensees around the world making some of the most innovative wearables and hearables on the market. Valencell also has the most-cited patent portfolio in active signal characterization, which includes 31 granted patents at the foundation of accurate biometric wearables and more than 70 additional patents pending.

Valencell licenses its biometric sensor technology to enable customers to create custom-designed biometric wearable devices. Valencell also recently introduced BioPack™, a turn-key biometric sensor system with the complete PerformTek technology package ready for immediate integration into wearable devices. This funding will help fuel immense early demand for BioPack.

"The market is now recognizing the value of accuracy in biometric wearables that Valencell provides, and the funding led by GII Tech will enable us to fuel our growth with additional investments in R&D, business development and go-to-market resources," said Michael Dering, CEO, Valencell. "This funding is a huge vote of confidence for Valencell's team, technology and business model that is enabling highly accurate biometrics in wearables of all kinds."

The wearables market recently recorded its eleventh consecutive quarter of steady growth. According to IDC, vendors shipped a total of 27.4 million wearables in the fourth quarter of 2015 alone, a 126.9 percent increase from the same quarter 2014. For the full year, vendors shipped a total of 78.1 million units, up a strong 171.6 percent over 2014.

About Valencell
Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell's PerformTek® biometric sensor technology employs active signal characterization to actively characterize biophysical signals for removing physical noise and extracting highly accurate biometric information. Valencell's sensor systems are the most accurate wearable biometric technology that continuously measure heart rate, activity, and other critical biometrics. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.

About GII and GII Tech
GII is a UAE-based financial services company certified by the Emirates Securities and Commodities Authority (ESCA). The company is committed to providing a diverse set of unique, duly researched, well-structured and risk-mitigated shari'ah compliant investment opportunities to its clients, with a view to achieve consistent and superior returns in the fields of venture capital, private equity, infrastructure and real estate.

Under the leadership of a committed group of prominent shareholders and investors, the GII team enjoys a collective experience in investments, strategic management, finance and accounting. GII and its team have a track record of managing $2.5 billion in assets and securing $5.5 billion in debt and in excess of $1.0 billion in equity and M&A financing.

GII's venture fund, GII Tech, focuses on disruptive category creators within the technology domain. The platform leverages GII's offshore business development experience in the GCC, MENA, Asia, and Turkey to facilitate the international market penetration of its portfolio companies, as well as provides them with invaluable access to an exclusive network of UNHWIs and institutional investors.

To learn more, visit us at and, or contact us at





SOURCE Valencell
Copyright©2016 PR Newswire.
All rights reserved

Related biology news :

1. Valencell, Inc. Selected as Showcase Company at CED Tech Venture Conference 2014
2. Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015
3. Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist
4. Valencell Sees Second Consecutive Year of Triple Digit Growth
5. LaserLock Technologies Files A New Provisional Patent Which Secures Player Identity On Internet Gaming Platforms
6. Smart Technology Consumers Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet
7. Fuel3D Secures $6.4 Million in Expansion Funding
8. Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner
9. higi secures over $40 million of funding - expands growth of the largest retail, omni-channel community health and wellness platform in the nation
10. Scientists awarded $5.5 million for wheat, rice blast research
11. UnitedHealth Group grants more than $1 million for the heart of New Ulm project
Post Your Comments:
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program ... honoring scientists who have made outstanding contributions to analytical chemistry and ... 2018, the world’s leading conference and exposition for laboratory science, which will be ...
(Date:10/9/2017)... Antonio, Texas (PRWEB) , ... ... ... new study published on October 5, 2017, in the medical journal, Epilepsia, ... equivalence with the gold standard, video EEG, in detecting generalized tonic-clonic seizures ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology: